الفهرس 
Biomechanics of Osteoporotic FracturesOnly 14 pages are availabe for public view
 |  | from | 113 |  |  |
| | | from | 113 | | |
Abstract
Background : Teriparatide , a synthetic parathyroid hormone ,increase the bone formation and bone mass . The known regimen is 20 mcg /day, through the subcutaneous injection. Method : Searching electronic database for its effect on prevention of both vertebral and non-vertebral fractures among postmenopausal women with osteoporosis . Results : Through 23 results, following the inclusion criteria , incidence of both vertebral and non-vertebral fractures was significantly decreased with teriparatide treatment , with different dosage (20mcg/day , 56.5 mcg/week and 28.2 mcg/week ) . Conclusion : teriaparatide decrease the risk of both vertebral and non-vertebral fractures among postmenopausal women with osteoporosis , and the effect on vertebral fractures being higher